On Demand Webcast

A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Gain expert insights into best practices and emerging strategies in CAR T-cell therapy for patients with leukemia, lymphoma, and myeloma with this dynamic online educational program based on a live Webinar. Download slides with all the key data, watch the on-demand Webcast, and join the conversation around an expert-authored commentary.

Renier J. Brentjens, MD, PhD
Program Director

Frederick L. Locke, MD

Noopur Raje, MD

On Demand Webcast

Multimedia

A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

View Multimedia

In this interactive on-demand Webcast, expert faculty members discuss how they currently use CAR T-cells to treat hematologic malignancies and provide a look ahead at new data and promising agents that may soon change practice.

Renier J. Brentjens, MD, PhD
Program Director

Frederick L. Locke, MD

Noopur Raje, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 1.75 Medical Knowledge MOC point(s) Released: December 8, 2020 Expired: No longer available for credit

A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Leaving the CCO site